Abstract
Since the early 1990s, the Food and Drug Administration (FDA) has focused attention on Good Manufacturing Practice (GMP) compliance within the active pharmaceutical ingredients (API) industry. Over the years, as well as recently, this industry has striven to play catch-up and comply. This paper discusses both general and specific API industry trends associated with this increased compliance effort.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Angelucci, L.A. Current Good Manufacturing Practice Design Trends in Active Pharmaceutical Ingredients Facilities. Ther Innov Regul Sci 33, 739–746 (1999). https://doi.org/10.1177/009286159903300312
Published:
Issue Date:
DOI: https://doi.org/10.1177/009286159903300312